Stereotactic body radiation therapy plus chemotherapy improves survival among stage 4 lung cancer patients
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients
Source: UT Southwestern Medical Center News - Category: Hospital Management Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Hospital Management | Lung Cancer | Radiation Therapy